Europe Urology Laser Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
|
 CAGR |
% |
| Major Markets Players |
>欧洲泌尿科激光市场，按激光类型（钬钇铝石榴石 (Ho:Yag)、铥钇铝石榴石 (Thu:Yag)、掺钕钇铝石榴石 (Nd:Yag)、钾钛氧磷酸钇铝石榴石 (Ktp:Yag)、二极管激光器、铒：钇铝石榴石激光器、硼酸锂等）、方式（便携式和独立式）、应用（尿石症、良性前列腺增生 (BPH)、部分肾切除术、肾结石去除、尿道狭窄、肿瘤等）、最终用户（医院、泌尿科诊所、门诊手术中心等）、分销渠道（直接招标、零售销售、在线销售等） - 行业趋势和预测到 2030 年。
欧洲泌尿科激光市场分析与洞察
由于欧洲泌尿科疾病患者数量不断增加，以及对非侵入性手术的倾向性增加，欧洲泌尿科激光市场预计将会发展。泌尿科激光设备的产品审批和研发活动的增加也影响了市场。然而，欧洲泌尿科激光市场预计将受到泌尿科激光设备和手术的高成本、与激光手术相关的安全问题和不良影响以及对激光设备治疗缺乏认识的阻碍。
激光技术的进一步技术进步和新兴企业的战略举措有望为市场增长带来机遇。然而，严格的法规和缺乏熟练的专业人员对市场增长构成挑战。
发达国家和发展中国家对泌尿科激光市场的需求都在增加，其背后的原因是这些系统能够提供高效的激光组织相互作用。因此，许多市场参与者都在提供创新的泌尿科激光产品，为欧洲泌尿科激光市场的增长铺平道路。
Data Bridge Market Research分析，2023年至2030年欧洲泌尿科激光市场将以5.2%的复合年增长率增长。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制 2016 - 2020） |
|
定量单位 |
收入（千）、销量（台）、定价（美元） |
|
涵盖的领域 |
激光器类型（钬钇铝石榴石 (Ho:Yag)、铥钇铝石榴石 (Thu:Yag)、掺钕钇铝石榴石 (Nd:Yag)、钾钛磷酸钇铝石榴石 (Ktp:Yag)、二极管激光器、铒：钇铝石榴石激光器、硼酸锂等）、方式（便携式和独立式）、应用（尿石症、良性前列腺增生 (BPH)、部分肾切除术、肾结石去除、尿道狭窄、肿瘤等）、最终用户（医院、泌尿科诊所、门诊手术中心等）、分销渠道（直接招标、零售销售、在线销售等） |
|
覆盖国家 |
德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、比利时和欧洲其他地区 |
|
涵盖的市场参与者 |
BD、Richard Wolf GmbH.、Olympus Corporation、Coherent, Inc.、Rocamed、Dornier MedTech、Limmer Laser GmbH、Gigaalaser、Boston Scientific Corporation、Cook、OmniGuide Holdings, Inc. 和 Allengers 等。 |
市场定义
激光技术基于设备发射高度聚焦的窄光束的能力。激光介质定义了每个 LASER（受激辐射光放大）系统中的波长。由于设备发出的平行辐射焦点小、强度高，因此很容易聚焦在目标上。泌尿科激光器是用于切除尿道、膀胱、输尿管和肾脏肿瘤的医疗设备或组件。泌尿科激光器发射微小的光束，提供准确、精确且无痛的手术治疗。
目前泌尿科最常用的激光器有Ktp：Yag（磷酸钛氧钾）、Lbo：Yag（硼酸锂）、二极管激光器、钬（Ho）：Yag、铥（Tm）：Yag激光器。
欧洲泌尿科激光市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
驱动程序
- 欧洲泌尿系统疾病患者数量不断增加
泌尿系统疾病影响各个年龄段的人，是老年患者最常见的临床疾病之一。许多泌尿系统疾病的发病率和患病率随着年龄的增长而增加。与其他年龄段相比，老年人口增长迅速。随着人口结构不断变化，对具有老年病学和老龄化专业知识的泌尿科医生的需求将不断增加。这些疾病可能导致残疾和生活质量下降。常见的泌尿系统疾病包括尿失禁、尿石症、泌尿系统癌症和前列腺癌。
泌尿系统疾病病例的增加对激光设备的需求产生了积极影响。因此，预计泌尿系统疾病患者数量的增加将在预测期内推动市场增长。
- 泌尿科激光设备的研发活动不断增加
研发对于所有行业都至关重要，医疗行业也不例外。医疗行业开展大量研发以创造收入，通常通过挽救或改善患者的生活来挽救生命。
研发 (R&D) 是市场参与者发现泌尿科激光器新技术的先决条件。市场参与者专注于开发泌尿科激光器以满足尚未满足的医疗需求。
近年来，激光技术已成为治疗前列腺增生、膀胱肿瘤、泌尿系统结石、尿道狭窄或外生殖器病变等疾病的一种越来越流行的治疗方法，这增加了泌尿科激光设备的研究和开发。因此，研发部门与市场参与者合作，在预测期内投资新型泌尿科激光设备的预期成本。
机会
- 激光技术的技术进步
技术进步被认为是泌尿科激光市场的主要驱动力。泌尿科激光治疗前列腺增生、膀胱肿瘤和泌尿系统结石等疾病，既方便又有效。
因此，泌尿科激光在治疗市场中占有重要地位。此外，它还用于检查和治疗泌尿系统中的囊肿、肿瘤或异常组织。主要市场参与者在激光市场取得了新的进展，以满足所需的疾病治疗需求。
在早期历史中，人们对泌尿科和疾病的理解迅速扩展。当原始泌尿科医生宣传使用尿液作为治疗物质的想法时，现代泌尿科医生发现了通过应用下一代 MOSES 2.0 钬激光技术等技术发展来远程切除肾脏的想法。
泌尿科激光设备技术应用的激增将导致劳动力减少、泌尿科疾病的治疗和恢复速度加快。未来，激光技术将取代手动泌尿科设备。激光设备减少了手术器械的使用。因此，预计在预测期内，它将成为市场增长的机会。
- 新兴企业的战略举措
主要参与者正在尝试制定具体策略，例如产品发布、收购、批准、扩张和合作，以确保业务顺利运行，避免风险，并增加市场销售的长期增长。这相应地有助于增加消费者对产品的需求，从而增加未来的销售额。
由于技术进步和全球泌尿系统疾病发病率的上升，泌尿系统激光设备的需求正在增加。顶级市场参与者已经实施了某些计划，旨在提高泌尿系统激光市场的运营和盈利能力。这些公司采取了收购、合作、产品订单等具体策略，为泌尿系统激光设备的国际市场创造机会。
市场参与者的这些战略举措，包括收购、会议和重点细分产品发布，正在帮助公司发展并改善公司的产品组合，最终带来更多收入。因此，市场参与者的这些战略举措为在预测期内推动市场增长提供了机会。
克制/挑战
- 泌尿科激光设备和手术费用高昂
泌尿科激光设备的制造和购买成本可能很高，而且由于需要专门的设备和培训，手术费用也可能很高。这可能会限制患者和医疗机构接受泌尿科激光治疗的机会，尤其是在低收入地区。此外，泌尿科激光设备和手术的高昂成本可能会阻止一些患者选择这些治疗，尤其是如果他们必须自掏腰包的话。泌尿科激光治疗的保险覆盖范围也可能有限，从而限制了其采用。
因此，泌尿科激光设备和手术的高成本可能成为欧洲泌尿科激光市场增长的重大障碍，尤其是在成本是主要因素的地区。然而，随着技术的进步，这些设备和手术的成本可能会下降，使患者和医疗机构更容易接受它们。
预计泌尿科激光设备的复杂程度增加以及泌尿科激光治疗的高成本将 在预测期内抑制市场的增长。
近期发展
- 2022 年 5 月，OmniGuide Holdings 宣布，美国食品和药物管理局批准其即将推出的产品 RevoLix HTL，这是一组脉冲和连续波铥 YAG 激光器，因此为接受 BPH 和结石管理手术的泌尿科患者提供 RevoLix 治疗的基础。随着 FDA 批准独立阅读器，该公司预计将产生更多收入。
欧洲泌尿科激光市场范围
泌尿科激光市场分为五个主要部分，即激光类型、模式、应用、最终用户和分销渠道。这些部分之间的增长将帮助您分析行业中的市场增长部分，并为用户提供有价值的市场概览和见解，帮助他们做出战略决策以确定核心市场应用。
激光类型
- 钬钇铝石榴石 (Ho:Yag)
- 铥钇铝石榴石 (Thu:Yag)
- 掺钕钇铝石榴石 (Nd:Yag)
- 磷酸钛氧钾钇铝石榴石 (Ktp:Yag)
- 二极管激光器
- 铒：钇铝石榴石激光器
- 硼酸锂
- 其他的
根据激光器类型，泌尿科激光市场细分为钬钇铝石榴石（Ho：Yag）、铥钇铝石榴石（Thu：Yag）、掺钕钇铝石榴石（Nd：Yag）、钾钛氧磷酸钇铝石榴石（Ktp：Yag）、二极管激光器、铒：钇铝石榴石激光器、硼酸锂等。
情态
- 便携的
- 独立
根据基础模式，泌尿科激光市场分为独立式和便携式。
应用
- 泌尿系统结石
- 良性前列腺增生 (BPH)
- 部分肾切除术
- 去除肾结石
- 尿道狭窄
- 肿瘤
- 其他的
根据应用，泌尿科激光市场分为尿路结石、良性前列腺增生 (BPH)、部分肾切除术、肾结石去除、尿道狭窄、肿瘤等。
最终用户
- 医院
- 泌尿科诊所
- 门诊手术中心
- 其他的
根据最终用户，泌尿科激光市场分为医院、泌尿科诊所、门诊手术中心和其他。
分销渠道
- 直接招标
- 零售销售
- 网上销售
- 其他的
根据分销渠道，泌尿科激光市场分为直接招标零售、在线销售和其他。
欧洲泌尿科激光市场区域分析/见解
对欧洲泌尿科激光市场进行了分析，并根据类型、方式、应用、最终用户和分销渠道提供了市场规模洞察和趋势。
本市场报告涵盖的国家包括德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、比利时和欧洲其他国家。
由于医疗服务技术水平不断提高、可靠性不断提高，德国有望成为欧洲的领军者。随着医疗数据与便携式设备的日益融合，泌尿科疾病的发病率预计将上升，从而推动该地区医疗需求的增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了区域品牌的存在和可用性及其由于来自本地和国内品牌的大量或稀缺竞争而面临的挑战以及国内关税和贸易路线的影响。
竞争格局和欧洲泌尿科激光市场份额分析
泌尿科激光市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、区域业务、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、品牌分析、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对市场的关注有关。
欧洲泌尿科激光市场的主要参与者包括 BD、Richard Wolf GmbH.、Olympus Corporation、Coherent, Inc.、Rocamed、Dornier MedTech、Limmer Laser GmbH、Gigaalaser、Boston Scientific Corporation、Cook、OmniGuide Holdings, Inc. 和 Allengers 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE UROLOGY LASER MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 IMPORT-EXPORT ANALYSIS
4.3.1 IMPORT
4.3.2 EXPORT
4.4 STRATEGIC INITIATIVES
4.5 PRICING ANALYSIS
4.6 ADOPTION OF LASER
5 EUROPE UROLOGY LASER MARKET, EPIDEMIOLOGY
5.1 INCIDENCE AND PREVALENCE OF UROLOGY DISORDERS, BY COUNTRY
5.2 UROLITHIASIS
5.3 BENIGN PROSTATIC HYPERPLASIA (BPH)
5.4 PARTIAL KIDNEY RESECTION
5.5 KIDNEY STONES
5.6 URETHRAL STRICTURES
5.7 TUMORS
6 EUROPE UROLOGY LASER MARKET, REGULATIONS
6.1 REGULATORY SCENARIO IN THE U.S.
6.2 REGULATORY SCENARIO IN AUSTRALIA
6.3 REGULATORY SCENARIO IN INDIA
6.4 REGULATORY SCENARIO IN U.K.
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING NUMBER OF PATIENTS RELATED TO UROLOGY DISORDERS EUROPELY
7.1.2 INCREASED INCLINATION TOWARDS NON-INVASIVE SURGERIES
7.1.3 RISE IN THE NUMBER OF PRODUCT APPROVAL FOR LASER DEVICES
7.1.4 RISING RESEARCH AND DEVELOPMENT ACTIVITIES FOR UROLOGY LASER DEVICES
7.2 RESTRAINTS
7.2.1 HIGH COST OF UROLOGY LASER DEVICE AND PROCEDURE
7.2.2 SAFETY CONCERNS AND ADVERSE EFFECTS ASSOCIATED WITH LASER PROCEDURES SAFETY CONCERNS
7.2.3 LACK OF AWARENESS ABOUT TREATMENT FOR UROLOGICAL CONDITIONS
7.3 OPPORTUNITIES
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN LASER TECHNOLOGY
7.3.2 STRATEGIC INITIATIVES BY EMERGING PLAYERS
7.4 CHALLENGES
7.4.1 LACK OF SKILLED PROFESSIONALS
7.4.2 STRINGENT REGULATIONS
8 EUROPE UROLOGY LASER MARKET, BY LASER TYPE
8.1 OVERVIEW
8.2 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
8.3 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
8.4 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
8.5 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
8.6 DIODE LASER
8.7 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
8.8 LITHIUM BORATE
8.9 OTHERS
9 EUROPE UROLOGY LASER MARKET, BY MODALITY
9.1 OVERVIEW
9.2 PORTABLE
9.3 STANDALONE
10 EUROPE UROLOGY LASER MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 UROLITHIASIS
10.2.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.2.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.2.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.2.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.2.5 DIODE LASER
10.2.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.2.7 LITHIUM BORATE
10.2.8 OTHERS
10.3 BENIGN PROSTATIC HYPERPLASIA (BPH)
10.3.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.3.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.3.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.3.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.3.5 DIODE LASER
10.3.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.3.7 LITHIUM BORATE
10.3.8 OTHERS
10.4 PARTIAL KIDNEY RESECTION
10.4.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.4.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.4.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.4.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.4.5 DIODE LASER
10.4.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.4.7 LITHIUM BORATE
10.4.8 OTHERS
10.5 REMOVAL OF KIDNEY STONES
10.5.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.5.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.5.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.5.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.5.5 DIODE LASER
10.5.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.5.7 LITHIUM BORATE
10.5.8 OTHERS
10.6 URETHRAL STRICTURES
10.6.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.6.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.6.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.6.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.6.5 DIODE LASER
10.6.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.6.7 LITHIUM BORATE
10.6.8 OTHERS
10.7 TUMORS
10.7.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.7.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.7.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.7.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.7.5 DIODE LASER
10.7.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.7.7 LITHIUM BORATE
10.7.8 OTHERS
10.8 OTHERS
10.8.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.8.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.8.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.8.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.8.5 DIODE LASER
10.8.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.8.7 LITHIUM BORATE
10.8.8 OTHERS
11 EUROPE UROLOGY LASER MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 UROLOGICAL CLINICS
11.4 AMBULATORY SURGICAL CENTERS
11.5 OTHERS
12 EUROPE UROLOGY LASER MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.4 ONLINE SALES
12.5 OTHERS
13 EUROPE UROLOGY LASER MARKET, BY REGION
13.1 EUROPE
13.1.1 GERMANY
13.1.2 U.K.
13.1.3 ITALY
13.1.4 FRANCE
13.1.5 SPAIN
13.1.6 RUSSIA
13.1.7 SWITZERLAND
13.1.8 TURKEY
13.1.9 BELGIUM
13.1.10 NETHERLANDS
13.1.11 REST OF EUROPE
14 EUROPE UROLOGY LASER MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 BOSTON SCIENTIFIC CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 COOK
16.2.1 COMPANY SNAPSHOT
16.2.2 COMPANY SHARE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 OLYMPUS CORPORATION
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 COHERENT, INC.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 DORNIER MEDTECH
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ADVIN HEALTH CARE
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 ALLENGERS
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 BD
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENTS
16.9 BIOLITEC AG
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 BISON MEDICAL
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 CONVERGENT LASER TECHNOLOGIES
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 EMS UROLOGY
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 GIGAALASER
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 HEALTHWARE PVT LTD.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 HYPERPHOTONICS.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 INTERMEDIC ARFRAN
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 LIMMER LASER GMBH
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 MONOCROM
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 OMNIGUIDE HOLDINGS, INC.
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 POTENT MEDICAL.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 QUANTA SYSTEM
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 RICHARD WOLF GMBH.
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 ROCAMED
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 SURGICAL LASERS INC.
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 TRIMEDYNE, INC.
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 UNIQUE MEDICAL DEVICES
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 IN 2022, ACCORDING TO THE ARTICLE PUBLISHED BY ELSEVIER LTD, THE FOLLOWING WAS THE DATA ON THE PREVALENCE AND INCIDENT RATES OF BPH IN 2019
TABLE 2 FOLLOWING TABLES SHOW TOTAL EUROPE KIDNEY CANCER INCIDENCE AND RATES IN 2020 FOR COUNTRIES WITH THE HIGHEST RATES OF KIDNEY CANCER/TUMORS.
TABLE 3 EUROPE UROLOGY LASER MARKET, BY LASER TYPE, 2021-2030 (USD THOUSAND)
TABLE 4 EUROPE HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 5 EUROPE THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 6 EUROPE NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 EUROPE POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 8 EUROPE DIODE LASER IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 9 EUROPE ERBIUM: YTTRIUM ALUMINUM GARNET LASER IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 EUROPE LITHIUM BORATE IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 11 EUROPE OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 EUROPE UROLOGY LASER MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)
TABLE 13 EUROPE PORTABLE IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 14 EUROPE STANDALONE IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 15 EUROPE UROLOGY LASER MARKET, BY APPLICATION 2021-2030 (USD THOUSAND)
TABLE 16 EUROPE UROLITHIASIS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 EUROPE UROLITHIASIS IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 18 EUROPE BENIGN PROSTATIC HYPERPLASIA (BPH) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 19 EUROPE BENIGN PROSTATIC HYPERPLASIA (BPH) IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 20 EUROPE PARTIAL KIDNEY RESECTION IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 21 EUROPE PARTIAL KIDNEY RESECTION IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 22 EUROPE REMOVAL OF KIDNEY STONES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 23 EUROPE REMOVAL OF KIDNEY STONES IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 24 EUROPE URETHRAL STRICTURES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 25 EUROPE URETHRAL STRICTURES IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 26 EUROPE TUMORS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 27 EUROPE TUMORS IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 28 EUROPE OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 29 EUROPE OTHERS IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 30 EUROPE UROLOGY LASER MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 31 EUROPE HOSPITALS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 EUROPE UROLOGICAL CLINICS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 EUROPE AMBULATORY SURGICAL CENTERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 34 EUROPE OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 35 EUROPE UROLOGY LASER MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 36 EUROPE DIRECT TENDER IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 37 EUROPE RETAIL SALES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 38 EUROPE ONLINE SALES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 39 EUROPE OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
图片列表
FIGURE 1 EUROPE UROLOGY LASER MARKET: SEGMENTATION
FIGURE 2 EUROPE UROLOGY LASER MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE UROLOGY LASER MARKET: DROC ANALYSIS
FIGURE 4 EUROPE UROLOGY LASER MARKET: EUROPE VS. REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE UROLOGY LASER MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE UROLOGY LASER MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE UROLOGY LASER MARKET: MULTIVARIATE MODELLING
FIGURE 8 EUROPE UROLOGY LASER MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE UROLOGY LASER MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE UROLOGY LASER MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 EUROPE UROLOGY LASER MARKET: SEGMENTATION
FIGURE 12 RISING NUMBER OF PATIENT RELATED TO UROLOGY DISORDER AND I INCREASED INCLINATION TOWARDS NON-INVASIVE SURGERIES IS EXPECTED TO DRIVE THE EUROPE UROLOGY LASER MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 13 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE UROLOGY LASER MARKET IN 2023 & 2030
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE UROLOGY LASER MARKET
FIGURE 15 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, 2022
FIGURE 16 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, 2023-2030 (USD THOUSAND)
FIGURE 17 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, CAGR (2023-2030)
FIGURE 18 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, LIFELINE CURVE
FIGURE 19 EUROPE UROLOGY LASER MARKET: BY MODALITY, 2022
FIGURE 20 EUROPE UROLOGY LASER MARKET: BY MODALITY, 2023-2030 (USD THOUSAND)
FIGURE 21 EUROPE UROLOGY LASER MARKET: BY MODALITY, CAGR (2023-2030)
FIGURE 22 EUROPE UROLOGY LASER MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 23 EUROPE UROLOGY LASER MARKET: BY APPLICATION, 2022
FIGURE 24 EUROPE UROLOGY LASER MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 25 EUROPE UROLOGY LASER MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 26 EUROPE UROLOGY LASER MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 EUROPE UROLOGY LASER MARKET: BY END USER, 2022
FIGURE 28 EUROPE UROLOGY LASER MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 29 EUROPE UROLOGY LASER MARKET: BY END USER, CAGR (2023-2030)
FIGURE 30 EUROPE UROLOGY LASER MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 32 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 33 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 34 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 EUROPE UROLOGY LASER MARKET: SNAPSHOT (2022)
FIGURE 36 EUROPE UROLOGY LASER MARKET: BY COUNTRY (2022)
FIGURE 37 EUROPE UROLOGY LASER MARKET: BY COUNTRY (2023 & 2030)
FIGURE 38 EUROPE UROLOGY LASER MARKET: BY COUNTRY (2022 & 2030)
FIGURE 39 EUROPE UROLOGY LASER MARKET: BY LASER TYPE (2023-2030)
FIGURE 40 EUROPE UROLOGY LASER MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
